Table 1 Significantly enriched functional pathways of gene regulation induced by different treatments between groups
Pathway name | Fold enrichment | P value | FDR | Pathway id |
|---|---|---|---|---|
NC versus FO | ||||
 ABC transporters | 7.271852 | 0.002065 | 0.215471 | rno02010 |
 Histidine metabolism | 10.1964 | 0.002952 | 0.215471 | rno00340 |
 Circadian rhythm | 8.685824 | 0.004692 | 0.228324 | rno04710 |
 Steroid hormone biosynthesis | 5.211494 | 0.006869 | 0.236681 | rno00140 |
 p53 signaling pathway | 4.963328 | 0.008141 | 0.236681 | rno04115 |
 Alanine, aspartate and glutamate metabolism | 6.700493 | 0.009727 | 0.236681 | rno00250 |
 Prolactin signaling pathway | 4.28342 | 0.013457 | 0.280675 | rno04917 |
 Cell cycle | 3.31239 | 0.016186 | 0.2954 | rno04110 |
 Arginine and proline metabolism | 4.187808 | 0.033798 | 0.493447 | rno00330 |
 Non-small cell lung cancer | 4.187808 | 0.033798 | 0.493447 | rno05223 |
 Retinol metabolism | 3.844545 | 0.041883 | 0.515193 | rno00830 |
 Transcriptional misregulation in cancer | 2.521691 | 0.044352 | 0.515193 | rno05202 |
 Pentose and glucuronate interconversions | 5.790549 | 0.045873 | 0.515193 | rno00040 |
FO versus DO | ||||
 Glycerolipid metabolism | 4.186519 | 0.0146 | 0.090976 | rno00561 |